Prot #CBI-cSCC: Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma

Project: Research project

StatusActive
Effective start/end date5/4/175/4/20

Funding

  • Castle Biosciences, Inc. (Prot #CBI-cSCC)